This document discusses congenital cranial dysinnervation disorders (CCDDs), which are a group of congenital neuromuscular diseases resulting from developmental errors in cranial nerve innervation. The document focuses on congenital fibrosis of the extraocular muscles (CFEOM), providing details on the classification, clinical features, genetics, and pathogenesis of different types of CFEOM. It also briefly discusses other CCDDs such as Duane syndrome and Möbius syndrome.
Gives a very brief review of how to evaluate a case of squint in day to day clinical practice. How to diagnose a basic abnormality of the movement of eye.
Gives a very brief review of how to evaluate a case of squint in day to day clinical practice. How to diagnose a basic abnormality of the movement of eye.
-IOL formula
1st generation formula : SRK, Binkhost
2nd generation formula : SRK II
3rd generation formula: Hoffer Q, Holladay 1, SRK/T
4th generation formula: Haigis, Holladay 2, Olsen
-The Hoffer Q, Holladay I, and SRK/T formula are all commonly used.
Slit lamp biomicroscopy and illumination techniquesLoknath Goswami
It is a presentation on slitlamp for beginner, shown the parts and different illumination techniques both for eye and contact lens and it have short history
-IOL formula
1st generation formula : SRK, Binkhost
2nd generation formula : SRK II
3rd generation formula: Hoffer Q, Holladay 1, SRK/T
4th generation formula: Haigis, Holladay 2, Olsen
-The Hoffer Q, Holladay I, and SRK/T formula are all commonly used.
Slit lamp biomicroscopy and illumination techniquesLoknath Goswami
It is a presentation on slitlamp for beginner, shown the parts and different illumination techniques both for eye and contact lens and it have short history
CME presentation on birth defect and Zika virus in pregnancy on 24 Feb 24, 2016 at Paropakar Maternity and Women's Hospital, Kathmandu: Way forward to Celebrating World Birth Defects Day on 3rd March 2016.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. Normal extraocular muscle (EOM) innervation
depends on-
◦ normal cranial nuclear motoneuron formation from
neuronal precursors,
◦ normal axonal path finding from the cranial nuclei
to developing EOMs, and
◦ the establishment and maintenance of normal
connections between mature neurons and their
target cells.
3. A number of well-defined syndromes
characterized by congenital limitation of eye
movements from abnormal innervation or
miswiring of EOMs have recently been grouped
as the “congenital
cranial dysinnervation disorders,” a term coined
for
congenital disorders resulting from aberrant
innervation of the ocular and facial
musculature.
4. Assaf proposed the term of ‘CID syndrome’.
Features of this syndrome include:
_ Congenital defect in the innervation EOMs.
_ Present since birth, and non-progressive.
_ Unilateral or bilateral
_ Findings are not explained by purely isolated
oculomotor nerve palsy/palsies.
_ Anatomical muscle changes, including tight muscle
_ can be associated with synkinesis phenomena
and/or co-contraction
_ abnormal head posture common
5. The term ‘congenital cranial dysinnervation disorders’ or CCDDs
was derived in 2002 at a European Neuromuscular Centre (ENMC)
international workshop by Gutowski et al for a group of congenital
neuromuscular diseases reflecting the belief that these disorders
resulted from developmental errors in innervation.
They define these disorders include-
CFEOM,
Congenital ptosis,
Duane’s syndrome,
Duane radial ray syndrome,
Horizontal gaze palsy with progressive scoliosis (HGPPS),
Mo¨bius syndrome.
The CCDDs also encompass developmental disorders of non-ocular
cranial nerves, such as congenital familial facial weakness.
6. They summarized the features of the CCDDs as
follows:
_ Congenital, non-progressive abnormalities of cranial
musculature that result from developmental abnormalities
of one or more cranial nerves with primary or secondary
muscle dysinnervation
_ Primary may result from absence of normal muscle
innervation. Secondary may occur from aberrant muscle
innervation during development by branches of other
nerves.
_ May be associated with secondary muscle pathology
and/or other orbital and bony structural abnormalities.
7. _ Predominantly, vertical ocular motility defects are likely to result
from abnormalities in development of oculomotor and trochlear
nerves and/or nuclei (CFEOM variants and congenital ptosis).
_ Predominantly horizontal ocular motility defects are likely to result
from abnormalities in the development of the abducens nerve
and/or nucleus (Duane’s syndrome and HGPPS).
_ Predominately facial weakness is likely to result from abnormal
development of facial nerve and/or nucleus, sometimes with
associated ocular motor abnormalities
(congenital facial weakness and Mo¨bius syndrome).
Recently, Kolling et al indicated congenital Brown’s syndrome is
caused by missing fourth cranial nerve in some cases, which put it
in the category of congenital dysinnervation.
8. The main CCDDs currently recognised and subdivided
1.Predominantly vertical disorder of ocular motility
• Congenital fibrosis of the extraocular muscles (CFEOM)
• Congenital ptosis
2.Predominantly horizontal disorder of ocular motility
• Duane syndrome (DS)
• DS + radial ray (DRRS)
• Horizontal gaze palsy with progressive scoliosis (HGPPS)
3.Disorder of facial motility
• Congenital facial palsy
4.Disorder of facial motility and ocular abduction
deficit
• Möbius syndrome
9. Congenital fibrosis of the extraocular muscles (CFEOM)
describes a group of rare congenital eye movement
disorders that result from the dysfunction of all or part of
the oculomotor (CN 3) and the trochlear (CN 4) nerves,
and/or the muscles these nerves innervate.
CFEOMs are characterized by –
◦ Variable impairment of horizontal and/or vertical eye
movements and ptosis.
◦ It can be unilateral or bilateral, with the bilateral form
being more common.
◦ Additional features include divergent strabismus and
abnormal head position, especially chin elevation
10. Congenital fibrosis syndrome has traditionally
been considered a primary muscle disorder
Ocular motility restrictions correlate with-
muscle hypoplasia
displaced scleral insertions
abnormal muscle substructure
Histopathologically, this condition is
characterized by degenerative muscle changes
and replacement of muscle fibres with fibrous
tissue.
11. Recently, CFEOM has been accepted to be of neurogenic
origin rather than primary muscle pathology.
α motoneurons of sup. division of III are present very
early in development, but disappear early-?apoptosis,
?necrosis
• Pulleys are normal-Demer
Engle EC., Leigh RJ.Genes, brainstem development and eye movements. Neurology
2002;59:304-305
12. 1. Histopathology-
◦ unreliable in distinguishing neurogenic from
myopathic ocular muscle weakness.
2. Co- contraction phenomenon-
◦ Co-contraction phenomenon resulting in globe
retraction has also been described in patients with
CFEOM.
13. 4. Electro-myographic studies:
Patients with CFEOM commonly have variable angle
strabismus.
Purely mechanical factors appear insufficient to explain this
variability, which more likely reflects innervational
disturbances.
Also, the degree of limitation of ocular movements in some
patients do not always correlate with the degree of tightness
of the agonist or antagonist muscle, as indicated by the
intraoperative forced duction test.
Nystagmus is another indicator of central ocular motor
disturbance in cases of CFEOM.
14. 4. Neuro-imaging
Abnormalities such as cerebellar hypoplasia and
asymmetrical ventricular size further hint at the
possibility of brain malformation.
Hence, cases of CFEOM have neurogenic aetiology
similar to that of DRS but involving the III cranial nerve
complex.
15. CFEOM refers to at least seven genetically
defined strabismus syndromes:
◦ CFEOM1A,
◦ CFEOM1B,
◦ CFEOM2,
◦ CFEOM3A,
◦ CFEOM3B,
◦ CFEOM3C, and
◦ Tukel syndrome
16. Affected individuals exhibit the following:
Congenital non-progressive bilateral external
ophthalmoplegia
Congenital non-progressive bilateral ptosis
Primary vertical position of each eye: infraducted
(downward)
Vertical eye movements: inability to elevate the eyes above
the horizontal midline
Primary horizontal position of each eye: normal
(orthotropic), inward (esotropic), or outward (exotropic)
Horizontal eye movements: normal to severely restricted
Aberrant eye movements: common, especially both eyes
turning inward on attempted upgaze
17. Forced duction test positive for restriction
Binocular vision: usually absent
Refractive errors: frequently high astigmatism
Amblyopia: may be strabismic or refractive in
nature
Pupils: normal
Family history: consistent with autosomal
dominant inheritance; simplex cases (i.e., a
single occurrence in a family) are observed.
Parental germline mosaicism can mimic
autosomal recessive inheritance.
18. CFEOM1 phenotype. A. Primary position showing marked bilateral
ptosis. B. Primary position with lids held showing resting globe
position. Both eyes remain infraducted below midline. C.
Attempted up gaze showing inability to reach midline with
convergence of the visual axis (synergistic convergence).
19. CFEOM- autosomal dominant inheritance with
full penetrance and minimal variation in
expression
CFEOM1 is divided into CFEOM1A and
CFEOM1B based on genetic findings.
◦ CFEOM1A is associated with mutations in KIF21A
gene; chr 12(centromeric region),
◦ CFEOM1B is associated with mutations in TUBB3
gene.
20. Affected individuals exhibit the following:
Congenital non-progressive bilateral external
ophthalmoplegia
Congenital non-progressive bilateral ptosis
Primary vertical position of each eye: normal or
positioned slightly above or below the midline
Vertical eye movements: severely restricted
Primary horizontal position of each eye: typically
fixed outward (exotropic) or rarely fixed in a
normal straight-ahead position (orthotropic)
Horizontal eye movements: severely restricted
21. Aberrant eye movements: small amplitude, if
present
Forced duction test: positive for restriction
Binocular vision: absent
Refractive errors: frequent
Amblyopia: frequent
Pupils: often small and sluggishly reactive to light
Genetics:
◦ autosomal recessive disorder
◦ mapped to chromosome 11g13.1.711
◦ result from mutations in the PHOX2A gene
22. CFEOM2
phenotype. A.
Primary position
showing bilateral
ptosis and
exotropia. B.
Primary
position with lids
held showing
resting globe
position. C.
Patient with right
face turn and
holding left upper
lid to clear
pupillary axis. D.
Miotic irregular
pupil.
23. Affected individuals may exhibit the following:
Lid position and movement: normal or congenital
non-progressive bilateral or unilateral ptosis
Primary vertical position of each eye: downward
(infraducted) or normal (primary position)
Vertical eye movements: variable restriction with
presence or absence of upgaze above the midline
Primary horizontal position of each eye: normal
(orthotropic) or outward (exotropic) may be more
common than inward (esotropic)
Horizontal eye movements: normal to severely
restricted
24. Aberrant eye movements: absent or present
Forced duction test: positive for restriction at
least in attempted upgaze
Refractive errors: absent or present
Binocular vision: absent or present
Pupils: normal
Magnetic resonance imaging of cranial nerves
and orbits: hypoplasia of the oculomotor
nerve and levator/superior rectus muscles
25. CFEOM3 is divided into CFEOM3A, CFEOM3B,
and CFEOM3C based on a combination of
clinical and genetic findings.
26. CFEOM3A refers to the CFEOM3 phenotype that
results from mutations in TUBB3.
a subset of individuals may have associated
findings, including:
◦ Intellectual disabilities
◦ Social disabilities
◦ Facial weakness
◦ Progressive sensorimotor axonal polyneuropathy
◦ Magnetic resonance imaging of the brain that reveals
dysgenesis of the corpus callosum, anterior commissure,
corticospinal tracts, and basal ganglia
◦ Family history consistent with autosomal dominant
inheritance
27. CFEOM3B refers to CFEOM3 when it results from
mutations in KIF21A.
◦ Affected individuals exhibit CFEOM3 as described above.
◦ Family history is consistent with autosomal dominant
inheritance.
CFEOM3C refers to a single family that co-segregates
CFEOM3 with a translocation.
◦ Affected family members harboring a balanced
translocation have the CFEOM3 phenotype.
◦ One affected member with an unbalanced translocation also
had facial dysmorphisms, kyphosis, pectus excavatum,
developmental delay, and motor regression.
◦ Family history is consistent with autosomal dominant
inheritance
28. CFEOM3A phenotype. A. Primary position. B. Right gaze with
absent adduction and slight down shoot OS. C. Left gaze with
absent adduction, slight down shoot OD, and limited abduction
OS. D. Attempted upgaze showing limitation OU with OS unable to
reach midline and with development of an esotropia. E. Down
gaze fixing OD with slight downward movement OD and only
outward movement of non-fixing OS. F. Down gaze fixing OS with
slight downward movement OS and only outward movement of
non-fixing OD
29. CFEOM3B phenotype. All images are in primary position. A.
Patient has unilateral ptosis and esotropia. B. Patient has severe
bilateral ptosis in primary position despite with marked frontalis
effort. C. Same patient as B in primary position with lids held
showing resting globe position marked by exotropia and
bilateral infraduction
30. Tukel syndrome. Affected individuals exhibit
the following:
◦ CFEOM3 phenotype
◦ Postaxial oligodactyly or oligosyndactyly of the
hands
◦ Family history: consistent with autosomal recessive
inheritance
32. Congenital non progressive ocular motility defect.
It was first described by Stilling and Turk.
The syndrome is characterized by limitation or absence of
abduction and/or adduction of the eyes.
There is also retraction of the globe and narrowing of the
palpebral fissure on adduction, which is often associated with
elevation or depression of the globes.
When abduction is attempted, one often finds widening of the
palpebral fissure
33. Pathological studies of DRS have provided clear evidence that
innervational deficiencies can cause fibrotic muscle changes.
Most cases are due to innervational defects, which correlate
with aplasia of the sixth nerve nucleus and the VI cranial nerve
itself
34. As shown by electrophysiological studies, innervation of the
lateral rectus is provided by the oculomotor nerve causing the
pathognomonic co-contraction of the medial and lateral recti
with globe retraction on adduction. (Synkinesis phenomenon)
Additionally, an association of DRS is seen with synkinesis
phenomena such as Marcus Gunn jaw-winking (due to
aberrant trigeminal nerve innervation of levator palpebrae
superioris)
35. autosomal dominant DRS- CHN1 gene mutation
human CHN1 mutations alter the development of
abducens and, to a lesser extent, oculomotor
axons.
DRS without systemic associations:
The DURS2 locus- on chromosome 2q31 l
(dominant DRS pedigree)
The DURS1 locus- on chromosome 8q12.2-8q21.2
(isolated DRS)
36. DRS with systemic associations
Of the various malformation syndromes, associated with DRS,
Duane radial ray syndrome has been genetically mapped.
inherited as dominant and with incomplete penetrance
mapped to chromosome 20
results from heterozygous nonsense frame shift, and deletion
mutations in SALL4
The SALL4 gene has also been implicated in DRS associated
with Holt–Oram and acro-renal-ocular syndromes.
37. Absence or hypoplasia of CN6 in the orbit or
brainstem regions, often with mild hypoplasia
and apparent misdirection of CN3 to the
lateral rectus muscle. (The LR muscle in
abducens palsy exhibits profound atrophy).
38. Type I
◦ Limitation / absence of abduction
◦ Norma/slightly defective adduction
◦ Narrowing of palpebral fissure & retraction of globe on
adduction
◦ Widening of fissure on abduction.
Type II
◦ Limitation / absence of adduction
◦ N/ slightly defective abduction
◦ Narrowing of PF & retraction of globe on adduction
Type III
◦ Limitation /absence of both abduction & adduction of
affected eye
◦ Retraction of globe & narrowing of PF on attempted
adduction.
39. Modification to Huber classification based on
primary position of gaze-
◦ Subgroup A- affected eye esotropic
◦ Subgroup B- exo
◦ Subgroup C- eyes straight in primary position.
40. Globe retraction
Narrowing of palpebral fissure on attempted
adduction
Abduction deficiency
Upshoot/downshoot on adduction
Small angle strabismus (usually <30 PD)
Face turn
Pattern: V more common than A.
42. heterogeneous clinical disorder, which includes congenital facial
palsy with impairment of ocular abduction
developmental disorder of the brainstem rather than an isolated
cranial nerve developmental disorder
The ocular motility disturbances in Mo¨bius syndrome are
frequently bizarre and asymmetrical, resembling more of a
congenital fibrosis pattern than cranial nerve palsies.
In a study of 37 patients with facial paresis by Verzijl et al, 97%
had bilateral and 3% had unilateral ocular abduction weakness.
43. Most cases are sporadic
Three Mo¨bius syndrome loci have been
mapped:
◦ MBS1 to 13q12.2-q13,
◦ MBS2 to 3q21-q22
◦ MBS 3 to 10q21.3-q22.1
44. Neural Imaging:
◦ Brain stem hypoplasia in the region of the sixth and
the seventh nerve complexes with or without other
posterior fossa abnormalities
◦ Hypoplasia of extraocular muscles and intraorbital
motor nerves
45. Some forms of congenital ptosis may result from aberrant
development of the unpaired caudal central oculomotor sub-
nucleus.
Two congenital ptosis loci are reported.
a. PTOS1 (1p32-p34.1)
Variable degree congenital unilateral or bilateral ptosis.
Inheritance is autosomal dominant with incomplete penetrance of
90%.
b. PTOS2 (Xp24-27.1)
Congenital bilateral symmetrical and severe ptosis almost impinging
on the visual axis in the primary position of gaze, with chin-up head
posture.
Inheritance is X-linked dominant (male and females are equally
affected).
46. Horizontal gaze palsy is suggested to result from hypoplasia of the abducens
nucleus with interneuron dysinnervation (medial longitudinal fasciculus and
pontine paramedian reticular formation).
ROBO3 [HGPPS (Horizontal gaze palsy with progressive scoliosis), 11q23-25.
The ROBO3 gene encodes a transmembrane receptor required for hindbrain axon
midline crossing.
HGPPS phenotype. There is congenital complete absence of conjugate horizontal
gaze and childhood onset progressive scoliosis.
Inheritance is autosomal recessive.
The uncrossed corticospinal and dorsal column pathways are not associated
with an obvious neurological deficit.
48. 1. Non surgical management-
◦ A. correction of refractive error & anisometropia
◦ Treatment of amblyopia.
2.surgical management-
◦ Indications of surgery-
Noticeable ocular deviation in primary position
Marked abnormal head posture
Marked globe retraction
Cosmetically unacceptaable upshoot or downshoot
49. Principles of surgery-
No resection procedure should be attempted ( worsens
movement limitation, retraction & upshoot & downshoot)
Recession of overacting muscle is safest & most effective
Adjustable sutures may be used when indicated.
Surgical options-
◦ For esotropia & face turn
Recession of I/L or B/L MR
Faden operation
Transposition of vertical recti to LR- risk of over &
under correction, of inducing vertical tropias & anterior
segement ischaemia.
50. ◦ For exotropia
I/L or B/L LR resection.
◦ For retraction & upshoot & downshoot:
I/L MR & LR recession. Posterior fixation suture may be
added.
Y- splitting with LR recession.
51. Non surgical management-
◦ Detection & treatment of amblyopia, corneal
exposure & refractive errors
Surgical management-
◦ No single surgery useful
◦ Transposition of vertical recti to insertion of LR
described
52. Non surgical management
◦ Correction of refractive error
◦ Treatment of amblyopia,
Surgical management-
◦ Correction of hypotropia, exotropia followed by
ptosis correction